| Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance M Wolff, R Evens, LJ Mertens, M Koslowski, F Betzler, G Gründer, ... Frontiers in psychiatry 11, 5, 2020 | 142 | 2020 |
| The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication R Evens, M Hoefler, K Biber, U Lueken Neuropsychologia 91, 163-172, 2016 | 58 | 2016 |
| Within and between session changes in subjective and neuroendocrine stress parameters during magnetic resonance imaging: A controlled scanner training study U Lueken, M Muehlhan, R Evens, HU Wittchen, C Kirschbaum Psychoneuroendocrinology 37 (8), 1299-1308, 2012 | 55 | 2012 |
| Neurostructural correlates of two subtypes of specific phobia: A voxel-based morphometry study K Hilbert, R Evens, NI Maslowski, HU Wittchen, U Lueken Psychiatry Research: Neuroimaging 231 (2), 168-175, 2015 | 43 | 2015 |
| Dopamine modulation of spatial navigation memory in Parkinson's disease F Thurm, NW Schuck, M Fauser, CF Doeller, Y Stankevich, R Evens, ... Neurobiology of Aging 38, 93-103, 2016 | 40 | 2016 |
| The impact of Parkinson’s disease and subthalamic deep brain stimulation on reward processing R Evens, Y Stankevich, M Dshemuchadse, A Storch, M Wolz, ... Neuropsychologia 75, 11-19, 2015 | 40 | 2015 |
| The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility M Wolff, LJ Mertens, M Walter, S Enge, R Evens Journal of Psychopharmacology 36 (3), 387-408, 2022 | 37 | 2022 |
| Fear processing in dental phobia during crossmodal symptom provocation: an fMRI study K Hilbert, R Evens, NI Maslowski, HU Wittchen, U Lueken BioMed research international 2014 (1), 196353, 2014 | 37 | 2014 |
| No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic A Bendau, L Viohl, MB Petzold, J Helbig, S Reiche, R Marek, ... International Journal of Drug Policy 102, 103582, 2022 | 31 | 2022 |
| The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics R Evens, ME Schmidt, T Majić, TT Schmidt Therapeutic Advances in Psychopharmacology 13, 20451253231172254, 2023 | 20 | 2023 |
| Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE)–Rationale and study design LJ Mertens, M Koslowski, F Betzler, R Evens, M Gilles, A Jungaberle, ... Neuroscience Applied 1, 100104, 2022 | 20 | 2022 |
| Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease U Lueken, R Evens, M Balzer‐Geldsetzer, S Baudrexel, R Dodel, ... International journal of methods in psychiatric research 26 (4), e1564, 2017 | 20 | 2017 |
| Psychedelic experiences during the early COVID-19 pandemic: findings from an international online survey R Evens, S Reiche, RM Marek, DU Moon, RE Groß, A Romanello, ... Frontiers in Psychiatry 12, 732028, 2021 | 15 | 2021 |
| Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ) M Wolff, R Evens, LJ Mertens, C Schmidt, J Beck, H Rutrecht, ... Journal of Psychopharmacology, 02698811241249698, 2024 | 8 | 2024 |
| Predictors of alcohol consumption among younger adults during the first phase of the COVID-19 pandemic L Brandt, R Evens, S Reiche, RM Marek, DU Moon, E Groß, A Romanello, ... Frontiers in Psychiatry 12, 748158, 2021 | 5 | 2021 |
| Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences J Mielau, S Reiche, DU Moon, E Groß, S Gutwinski, F Betzler, ... Frontiers in Psychiatry 13, 1037451, 2023 | 4 | 2023 |
| Resting-state functional connectivity in anxiety disorders: a multicenter fMRI study T Langhammer, K Hilbert, D Adolph, V Arolt, S Bischoff, J Böhnlein, ... Molecular Psychiatry, 1-10, 2024 | 2 | 2024 |
| Die Rolle der Psychotherapie in klinischen Studien mit Psychedelika R Evens, M Wolff Die Psychotherapie 69 (2), 85-91, 2024 | 1 | 2024 |
| PTBS-Diagnose im Wandel R Evens, ST Hizli, O Schulte-Herbrüggen DNP-Der Neurologe & Psychiater 20 (2), 48-56, 2019 | 1 | 2019 |
| The Afterglow Inventory (AGI)–validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics T Majic, TT Schmidt, A Gröticke, P Gasser, WA Richards, TG Riemer, ... Center for Open Science, 2024 | | 2024 |
